Pharmacokinetic Properties of ORM-14540 and ORM-12741 After Administration of a Microdose of 14C-Labelled Drug; An Open, Non-Randomised, Single Dose, Single Centre Study in Healthy Male Subjects.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 09 Dec 2009
At a glance
- Drugs ORM 12741; ORM 14540
- Indications Schizophrenia
- Focus Pharmacokinetics
- 09 Oct 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Feb 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Feb 2009 New trial record